These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37970476)

  • 1. Roles of phosphatidylinositol-3-kinases signaling pathway in inflammation-related cancer: Impact of rs10889677 variant and buparlisib in colitis-associated cancer.
    Razali NN; Raja Ali RA; Muhammad Nawawi KN; Yahaya A; Mohd Rathi ND; Mokhtar NM
    World J Gastroenterol; 2023 Oct; 29(40):5543-5556. PubMed ID: 37970476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.
    Lu ZH; Ding Y; Wang YJ; Chen C; Yao XR; Yuan XM; Bu F; Bao H; Dong YW; Zhou Q; Li L; Chen T; Li Y; Zhou JY; Wang Q; Shi GP; Jiang F; Chen YG
    J Ethnopharmacol; 2024 Oct; 333():118260. PubMed ID: 38685367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Sequencing of Cytokine-Induced PI3K-Related Genes in Ulcerative Colitis, Colorectal Cancer and Colitis-Associated Cancer.
    Razali NN; Raja Ali RA; Muhammad Nawawi KN; Yahaya A; Mokhtar NM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Baselga J; Im SA; Iwata H; Cortés J; De Laurentiis M; Jiang Z; Arteaga CL; Jonat W; Clemons M; Ito Y; Awada A; Chia S; Jagiełło-Gruszfeld A; Pistilli B; Tseng LM; Hurvitz S; Masuda N; Takahashi M; Vuylsteke P; Hachemi S; Dharan B; Di Tomaso E; Urban P; Massacesi C; Campone M
    Lancet Oncol; 2017 Jul; 18(7):904-916. PubMed ID: 28576675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
    Ma Y; Sender S; Sekora A; Kong W; Bauer P; Ameziane N; Al-Ali R; Krake S; Radefeldt M; Weiss FU; Lerch MM; Parveen A; Zechner D; Junghanss C; Murua Escobar H
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of microRNA-222-3p ameliorates ulcerative colitis and colitis-associated colorectal cancer to protect against oxidative stress
    Wang XJ; Zhang D; Yang YT; Li XY; Li HN; Zhang XP; Long JY; Lu YQ; Liu L; Yang G; Liu J; Hong J; Wu HG; Ma XP
    Front Immunol; 2023; 14():1089809. PubMed ID: 36776858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
    Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
    Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.
    Lee G; Goretsky T; Managlia E; Dirisina R; Singh AP; Brown JB; May R; Yang GY; Ragheb JW; Evers BM; Weber CR; Turner JR; He XC; Katzman RB; Li L; Barrett TA
    Gastroenterology; 2010 Sep; 139(3):869-81, 881.e1-9. PubMed ID: 20580720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
    Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway.
    Chen Q; Duan X; Fan H; Xu M; Tang Q; Zhang L; Shou Z; Liu X; Zuo D; Yang J; Deng S; Dong Y; Wu H; Liu Y; Nan Z
    Int Immunopharmacol; 2017 Dec; 53():149-157. PubMed ID: 29107215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.
    Cui H; Jin Y; Wang N; Liu H; Shu R; Wang J; Wang X; Jia B; Wang Y; Bian Y; Wen W
    Phytomedicine; 2024 Jun; 128():155509. PubMed ID: 38452403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
    McPherson V; Reardon B; Bhayankara A; Scott SN; Boyd ME; Garcia-Grossman IR; Regazzi AM; McCoy AS; Kim PH; Al-Ahmadie H; Ostrovnaya I; Roth AJ; Farooki A; Berger MF; Rosenberg JE; Solit DB; Van Allen E; Milowsky MI; Bajorin DF; Iyer G
    Cancer; 2020 Oct; 126(20):4532-4544. PubMed ID: 32767682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the PI3K signaling pathway: buparlisib as a new targeted option in breast carcinoma.
    Estévez LG; García E; Hidalgo M
    Clin Transl Oncol; 2016 Jun; 18(6):541-9. PubMed ID: 26510854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
    Sun A; Ge J; Ding K; Gao Z; Zhang Y
    Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer.
    Deng Y; Huang X; Chen X; Wang M; Tian L; Zhou H; Yang W; He F; Yin W
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer.
    Khan MW; Keshavarzian A; Gounaris E; Melson JE; Cheon EC; Blatner NR; Chen ZE; Tsai FN; Lee G; Ryu H; Barrett TA; Bentrem DJ; Beckhove P; Khazaie K
    Clin Cancer Res; 2013 May; 19(9):2342-54. PubMed ID: 23487439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
    Wen PY; Touat M; Alexander BM; Mellinghoff IK; Ramkissoon S; McCluskey CS; Pelton K; Haidar S; Basu SS; Gaffey SC; Brown LE; Martinez-Ledesma JE; Wu S; Kim J; Wei W; Park MA; Huse JT; Kuhn JG; Rinne ML; Colman H; Agar NYR; Omuro AM; DeAngelis LM; Gilbert MR; de Groot JF; Cloughesy TF; Chi AS; Roberts TM; Zhao JJ; Lee EQ; Nayak L; Heath JR; Horky LL; Batchelor TT; Beroukhim R; Chang SM; Ligon AH; Dunn IF; Koul D; Young GS; Prados MD; Reardon DA; Yung WKA; Ligon KL
    J Clin Oncol; 2019 Mar; 37(9):741-750. PubMed ID: 30715997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
    Sahin I; Azab F; Mishima Y; Moschetta M; Tsang B; Glavey SV; Manier S; Zhang Y; Sacco A; Roccaro AM; Azab AK; Ghobrial IM
    Am J Hematol; 2014 Nov; 89(11):1030-6. PubMed ID: 25060991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
    Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
    Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.